Skip to main content

UBS Group AG

Position in VERA — Vera Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in VERA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$10,906,947
+$3,348,255 QoQ
Shares Held
254,182
+35.3% QoQ
Ownership
0.353%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 217 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VERA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. VERA ranks #110 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VERA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,906,947 254,182
2026-03-31 $7,558,692 187,887
2025-12-31 $10,497,113 207,289
2025-09-30 $4,709,898 162,075
2025-06-30 $2,425,101 102,933
2025-03-31 $11,041,200 459,667
2024-12-31 $4,114,943 97,303
2024-09-30 $3,640,929 82,374
2024-06-30 $2,694,035 74,462
2024-03-31 $5,449,634 126,383
2023-12-31 $1,775,189 115,422
2023-09-30 $602,348 43,935
2023-06-30 $332,764 20,733
2023-03-31 $69,320 8,933
2022-12-31 $17,356 897
2022-09-30 $112,900 5,298
2022-06-30 $5,375 395
2022-03-31 $47,190 2,009
2021-06-30 $12,676 956